Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy scPharmaceuticals stock | $5.58

Own scPharmaceuticals stock in just a few minutes.

Fact checked

scPharmaceuticals Inc is a biotechnology business based in the US. scPharmaceuticals shares (SCPH) are listed on the NASDAQ and all prices are listed in US Dollars. scPharmaceuticals employs 26 staff and has a market cap (total outstanding shares value) of USD$148.9 million.

How to buy shares in scPharmaceuticals

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for scPharmaceuticals. Find the stock by name or ticker symbol: SCPH. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until scPharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$5.58, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of scPharmaceuticals, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of scPharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

scPharmaceuticals share price

Use our graph to track the performance of SCPH stocks over time.

scPharmaceuticals shares at a glance

Information last updated 2020-12-09.
Latest market closeUSD$5.58
52-week rangeUSD$4.25 - USD$11.99
50-day moving average USD$8.7084
200-day moving average USD$8.0949
Wall St. target priceUSD$11
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.445

Buy scPharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy scPharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

scPharmaceuticals price performance over time

Historical closes compared with the close of $5.58 from 2020-12-09

1 week (2021-01-08) -12.68%
1 month (2020-12-15) -2.79%
3 months (2020-10-15) -35.27%
6 months (2020-07-15) -28.64%
1 year (2020-01-15) -3.96%
2 years (2019-01-15) 44.37%
3 years (2018-01-12) 12
5 years (2016-01-11) N/A

scPharmaceuticals financials

Gross profit TTM USD$0
Return on assets TTM -22.28%
Return on equity TTM -47.72%
Profit margin 0%
Book value $3.287
Market capitalisation USD$148.9 million

TTM: trailing 12 months

Shorting scPharmaceuticals shares

There are currently 197,296 scPharmaceuticals shares held short by investors – that's known as scPharmaceuticals's "short interest". This figure is 1% down from 199,347 last month.

There are a few different ways that this level of interest in shorting scPharmaceuticals shares can be evaluated.

scPharmaceuticals's "short interest ratio" (SIR)

scPharmaceuticals's "short interest ratio" (SIR) is the quantity of scPharmaceuticals shares currently shorted divided by the average quantity of scPharmaceuticals shares traded daily (recently around 51245.714285714). scPharmaceuticals's SIR currently stands at 3.85. In other words for every 100,000 scPharmaceuticals shares traded daily on the market, roughly 3850 shares are currently held short.

However scPharmaceuticals's short interest can also be evaluated against the total number of scPharmaceuticals shares, or, against the total number of tradable scPharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case scPharmaceuticals's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 scPharmaceuticals shares in existence, roughly 10 shares are currently held short) or 0.0133% of the tradable shares (for every 100,000 tradable scPharmaceuticals shares, roughly 13 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against scPharmaceuticals.

Find out more about how you can short scPharmaceuticals stock.

scPharmaceuticals share dividends

We're not expecting scPharmaceuticals to pay a dividend over the next 12 months.

scPharmaceuticals share price volatility

Over the last 12 months, scPharmaceuticals's shares have ranged in value from as little as $4.25 up to $11.99. A popular way to gauge a stock's volatility is its "beta".

SCPH.US volatility(beta: 0.55)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while scPharmaceuticals's is 0.5484. This would suggest that scPharmaceuticals's shares are less volatile than average (for this exchange).

scPharmaceuticals overview

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site